BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Diagnosis
45 results:

  • 1. Non-invasive differential diagnosis of teratomas from other intracranial germ cell tumours using MRI-based fractal and radiomic analyses.
    Liu S; Wang X; Liu X; Li S; Liao H; Qiu X
    Eur Radiol; 2024 Mar; 34(3):1434-1443. PubMed ID: 37672052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021.
    Thiis-Evensen E; Boyar Cetinkaya R
    J Neuroendocrinol; 2023 Apr; 35(4):e13264. PubMed ID: 36988112
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
    Vo KT; DuBois SG; Neuhaus J; Braunstein SE; Weil BR; Naranjo A; Irtan S; Balaguer J; Matthay KK
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29616. PubMed ID: 35188340
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy.
    Thielmann CM; Matull J; Zaremba A; Murali R; Chorti E; Lodde G; Jansen P; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Kretz J; Möller I; Sucker A; Paschen A; Livingstone E; Zimmer L; Hadaschik E; Ugurel S; Schadendorf D; Griewank KG
    Eur J Cancer; 2022 Jan; 161():99-107. PubMed ID: 34936949
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs.
    Franken MG; Leeneman B; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; Boers-Sonderen MJ; van den Eertwegh AJM; de Groot JWB; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; van der Veldt AAM; Westgeest HM; Wouters MWJM; Haanen JBAG; Uyl-de Groot CA
    ESMO Open; 2021 Dec; 6(6):100320. PubMed ID: 34856511
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease.
    Erickson AW; Habbous S; Wright F; Lofters AK; Jerzak KJ; Das S
    JAMA Oncol; 2021 Aug; 7(8):1220-1224. PubMed ID: 34081080
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe.
    Sacchetto L; Rosso S; Comber H; Bouchardy C; Broganelli P; Galceran J; Hackl M; Katalinic A; Louwman M; Robsahm TE; Tryggvadottir L; Tumino R; Van Eycken E; Walsh PM; Zadnik V; Zanetti R
    Int J Cancer; 2021 Jun; 148(12):2898-2905. PubMed ID: 33497469
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preoperative Biopsy diagnosis in Pulmonary Carcinoids, a Shot in the Dark.
    Moonen L; Derks JL; Hermans BCM; Bunnik IM; Hillen LM; van Suylen RJ; den Bakker MA; von der Thüsen JH; Damhuis RA; van den Broek EC; Buikhuisen WA; Dingemans AC; Speel EJM
    J Thorac Oncol; 2021 Apr; 16(4):610-618. PubMed ID: 33333326
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017.
    Bosetti C; Traini E; Alam T; Allen CA; Carreras G; Compton K; Fitzmaurice C; Force LM; Gallus S; Gorini G; Harvey JD; Kocarnik JM; La Vecchia C; Lugo A; Naghavi M; Pennini A; Piccinelli C; Ronfani L; Xu R; Monasta L
    Sci Rep; 2020 Dec; 10(1):22099. PubMed ID: 33328623
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Indoor tanning exposure in association with multiple primary melanoma.
    Karapetyan L; Yang X; Wang H; Sander CA; Moyer A; Wilson M; Karunamurthy A; Kirkwood JM
    Cancer; 2021 Feb; 127(4):560-568. PubMed ID: 33170961
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.
    Johnson SC; Smith ZL; Nottingham C; Schwen ZR; Thomas S; Fishman EK; Lee NJ; Pierorazio PM; Eggener SE
    Urology; 2019 Jan; 123():186-190. PubMed ID: 30179635
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
    Ferris LK; Gerami P; Skelsey MK; Peck G; Hren C; Gorman C; Frumento T; Siegel DM
    Melanoma Res; 2018 Oct; 28(5):478-482. PubMed ID: 30004988
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.
    Stensjøen AL; Berntsen EM; Jakola AS; Solheim O
    Clin Neurol Neurosurg; 2018 Jul; 170():38-42. PubMed ID: 29727799
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Melanoma and tattoos: a case report and review of the literature.
    Ricci F; Paradisi A; Maier SA; Kovacs M; Podda M; Peris K; Abeni D
    Eur J Dermatol; 2018 Feb; 28(1):50-55. PubMed ID: 29171408
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
    Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
    J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade tumor.
    Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
    World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Melanoma of the external ear: A population-based study.
    Deep NL; Glasgow AE; Habermann EB; Kasperbauer JL; Carlson ML
    Am J Otolaryngol; 2017; 38(3):309-315. PubMed ID: 28258767
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain tumors.
    Li MD; Forkert ND; Kundu P; Ambler C; Lober RM; Burns TC; Barnes PD; Gibbs IC; Grant GA; Fisher PG; Cheshier SH; Campen CJ; Monje M; Yeom KW
    J Pediatr; 2017 Jun; 185():173-180.e3. PubMed ID: 28187964
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. tumor Regression After Brachytherapy for Choroidal Melanoma: Reduction of Thickness and Cross-Sectional Area by Shape and Regression Pattern.
    Rashid M; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2612-23. PubMed ID: 25813993
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.